A Smarter Approach to Opioid Stewardship

OptiOpioid is a digital clinical decision support tool for preoperative assessment. It identifies opioid medications in a patient's medication list, calculates the total oral morphine equivalent (OME) dose, and flags patients for review by the appropriate local service.

Request Evaluation Access

Regulatory status.

OptiOpioid is Software as a Medical Device. It is not yet UKCA marked and is not yet registered with the MHRA. The prototype is available for evaluation by invitation only and must not be used to inform patient care.

Calculate OME Doses

Calculates the total oral morphine equivalent (OME) dose from a patient's medication list, including modified-release and transdermal preparations.

Stratify Patient Risk

Utilises a clear traffic-light system to stratify patients, immediately highlighting those at higher risk of harm.

Aligned to National Standards

Applies published Faculty of Pain Medicine conversion factors and thresholds. The tool surfaces information; clinicians retain all clinical decision-making.

Why Preoperative Identification Matters

Patients taking regular opioids before surgery have higher pain scores, longer length of stay and higher rates of persistent postsurgical pain. National guidance recommends identification of opioid exposure before surgery. OptiOpioid is designed to make that identification consistent.

Demo Access

A prototype of the tool is available for evaluation by invitation only at this stage. Please contact us to express your interest in evaluating OptiOpioid.

Contact Us to Request Access

About the Founder

Headshot of Dr Hannah Dawe

"Inspired by the need for simple, scalable tools to reduce opioid-related harm and promote safe, patient-centred care across the NHS and wider healthcare system."

Dr Hannah Dawe FRCA FFPMRCA

Consultant Anaesthetist and Pain Medicine Specialist

Founder and Clinical Director, Guard-Rx Ltd